Sponsored By
DEA ‘synthetic cannabinoid’ statements raise concerns for CBD stakeholders.png?width=700&auto=webp&quality=10&disable=upscale&blur=40)
Supplement Regulations.png?width=700&auto=webp&quality=80&disable=upscale)
DEA ‘synthetic cannabinoid’ statements raise concerns for CBD stakeholdersDEA ‘synthetic cannabinoid’ statements raise concerns for CBD stakeholders
Stakeholders in the CBD industry are monitoring a DEA proposal concerning synthetic cannabinoids.
Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.